EuroMedica, Clinical Glutathione, 60 Slow Melt Tablets
UPC Code: 367703737061
Description
Clinical Glutathione featuring Sublinthion A First of Its Kind
Sublinthion is a unique, protected glutathione from France produced by a patented process. In a published human study, Clinical Glutathione with Sublinthion improved the reduced glutathione vs. oxidized glutathione blood ratios in the body by 230%.
Clinical Glutathione is specially formulated as a slow-melt tablet, protected by a unique, patented process. It supports beneficial levels of active glutathione in the bloodstream and improves the ratio of active glutathione to oxidized glutathione in a way that other approaches can’t.
Clinical Glutathione:
- Improves blood ratios by 230%
- Slow melt tablet for optimal benefits
- Clinically tested, European innovation
- Exclusive, patented, protected delivery system
Packaging
60 Slow Melt Tablets
Suggested Use
Take 2 tablets daily. One tablet in a.m. and one tablet in the p.m., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.
About EuroMedica
EuroMedica offers a full line of high quality, premium dietary supplements featuring clinically studied ingredients. Our unique formulations are rooted in our deep respect for traditional approaches, paired with a desire to continually advance the science of natural health and our commitment to innovation. We are truly passionate about providing effective, proven, high quality dietary supplements to support optimal health for your patients.
Safety
Do not use if pregnant or nursing. Keep out of reach of children. Please consult your health care provider if currently under care or treatment. Do not exceed recommended serving. See product packaging for additional safety information.
Disclaimer
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.